Crescita Therapeutics (TSX:CTX) Change In Receivables : C$1.02 Mil (TTM As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Crescita Therapeutics Change In Receivables?

Crescita Therapeutics's change in receivables for the quarter that ended in Mar. 2024 was C$-0.60 Mil. It means Crescita Therapeutics's Accounts Receivable increased by C$0.60 Mil from Dec. 2023 to Mar. 2024 .

Crescita Therapeutics's change in receivables for the fiscal year that ended in Dec. 2023 was C$3.54 Mil. It means Crescita Therapeutics's Accounts Receivable declined by C$3.54 Mil from Dec. 2022 to Dec. 2023 .

Crescita Therapeutics's Accounts Receivable for the quarter that ended in Mar. 2024 was C$3.45 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Crescita Therapeutics's Days Sales Outstanding for the three months ended in Mar. 2024 was 63.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Crescita Therapeutics's liquidation value for the three months ended in Mar. 2024 was C$8.73 Mil.

Crescita Therapeutics Change In Receivables Historical Data

The historical data trend for Crescita Therapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crescita Therapeutics Change In Receivables Chart

Crescita Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

2.81

1.43

-2.10

-2.44

3.54

Crescita Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															1.92	0.53	1.36	-0.27	-0.60

Crescita Therapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.02 Mil.

Crescita Therapeutics (TSX:CTX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Crescita Therapeutics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3.454	/	4.996	*	91
=	63.09

2. In Ben Graham's calculation of liquidation value, Crescita Therapeutics's accounts receivable are only considered to be worth 75% of book value:

Crescita Therapeutics's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	9.531	-	5.925	+	0.75 * 3.454	+	0.5 * 5.059
=	8.73

Crescita Therapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Crescita Therapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Crescita Therapeutics (TSX:CTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Crescita Therapeutics Inc (TSX:CTX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CRRTF:USA

Address

2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website

https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue in the form of product sales and out-licensing revenue.

Executives

Knight Therapeutics Inc.

10% Security Holder

Crescita Therapeutics (TSX:CTX) Headlines

No Headlines